Loading clinical trials...
Loading clinical trials...
A Retrospective, Multi-Center, Post-Market Clinical Follow-Up Study of Stryker Class IIb Implants
Retrospective, multi-center, chart review (only to include data that is part of the surgeons' standard practice)
The purpose of this study is to leverage standard of care data to provide further characterization of clinical outcomes following shoulder, hip and knee joint surgeries. * Primary Objective: To describe clinical outcomes of the Stryker Device in the shoulder, hip, and knee joints 6 months after surgical intervention. * Secondary Objective: To describe clinical outcomes of the Stryker Device in the shoulder, hip, and knee joints 3 months after surgical intervention. * Safety Objective: To describe safety of the Stryker implants in the shoulder, hip, and knee joints 6 months after intervention.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Musculoskeletal-Orthopedic Research and Education Foundation
Phoenix, Arizona, United States
Steadman Hawkins Clinic Denver
Englewood, Colorado, United States
TSAOG Orthopaedics & Spine
San Antonio, Texas, United States
Start Date
December 5, 2023
Primary Completion Date
June 30, 2026
Completion Date
December 1, 2026
Last Updated
May 29, 2025
1,500
ESTIMATED participants
Standard of Care Treatment
DEVICE
Lead Sponsor
Stryker Endoscopy
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06541756